<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00214123</url>
  </required_header>
  <id_info>
    <org_study_id>RO04502</org_study_id>
    <nct_id>NCT00214123</nct_id>
  </id_info>
  <brief_title>Hypofractionated Radiotherapy for Lung Cancer</brief_title>
  <official_title>The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to pilot reducing the duration of radiation treatment for lung
      cancer patients from 6 to 5 weeks using tomotherapy. Specific patient doses will be based on
      tumor volume being treated. Modeling has shown that increased biologically effective dose
      (BED) to tumors can be achieved by shortening the radiation delivery schedule and increasing
      the dose per fraction. This requires decreasing the total dose to hold lung toxicity constant
      at each dose per fraction level. This is a major paradigm shift in the treatment in this
      disease and is projected to result in significant improvements in patient outcome as well as
      a substantial cost savings.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grade 3 pneumonitis lasting greater than 2 weeks</measure>
    <time_frame>90 days post radiotherapy (XRT)</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Bin 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bin assignment based on tumor volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bin 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bin assignment based on tumor volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bin 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bin assignment based on tumor volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bin 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bin assignment based on tumor volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bin 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bin assignment based on tumor volume</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy (radiotherapy)</intervention_name>
    <description>Bin assignment based on tumor volume</description>
    <arm_group_label>Bin 1</arm_group_label>
    <arm_group_label>Bin 2</arm_group_label>
    <arm_group_label>Bin 3</arm_group_label>
    <arm_group_label>Bin 4</arm_group_label>
    <arm_group_label>Bin 5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Thoracic neoplasm requiring at lest 60 Gy conventional radiotherapy

        Exclusion Criteria:

          -  Prior bleomycin or gemcitabine chemotherapy

          -  Prior thoracic radiotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Traynor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin Hospital and Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>July 22, 2015</last_update_submitted>
  <last_update_submitted_qc>July 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

